GT Biopharma, Inc.·4

Sep 8, 5:45 PM ET

URBAN ALAN LOUIS 4

4 · GT Biopharma, Inc. · Filed Sep 8, 2025

Insider Transaction Report

Form 4
Period: 2025-09-04
Transactions
  • Award

    Option to purchase Common Stock

    2025-09-04+50,00050,000 total
    Exercise: $1.33Exp: 2035-08-19Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]The option vests in four equal quarterly installments beginning on January 1, 2025.
  • [F2]The option vests in four equal quarterly installments beginning on January 1, 2026.

Documents

1 file
  • 4
    ownership.xmlPrimary